You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Patent: 10,087,493


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,087,493
Title:Method for detecting infectious parvovirus in pharmaceutical preparations
Abstract: The present invention provides methods for detecting viral infectivity and content in an enzyme preparation. In certain embodiments, the invention relates to methods for producing a pharmaceutical pancreatic enzyme composition. In additional embodiments, the invention relates to detecting infectious porcine parvovirus (PPV) and determining PPV content in pancreatic enzyme preparations (PEPs), including pancrelipase preparations.
Inventor(s): Tijssen; Peter (Pointe-Claire, CA), Szelei; Jozsef (Laval, CA), Zadori; Zoltan (Montreal, CA)
Assignee: APTALIS PHARMA CANADA ULC (CA)
Application Number:12/400,145
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. The U.S. Patent and Trademark Office (USPTO) is responsible for granting these patents, and understanding the scope and claims of a patent is crucial for both inventors and competitors. This article will delve into the specifics of patent claims, the patent landscape, and use U.S. Patent 10,087,493 as a case study to illustrate key concepts.

What are Patent Claims?

Patent claims define the scope of protection granted by a patent. They are the legal boundaries that distinguish the invention from prior art and other existing technologies. Claims are typically divided into independent and dependent claims, with independent claims standing alone and dependent claims referring back to one or more independent claims[3].

Types of Patent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial in determining the scope of the patent.
  • Dependent Claims: These claims refer back to one or more independent claims and further limit the scope of the invention.

Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims[3].

The Patent Landscape

The patent landscape has evolved significantly over the years, influenced by legislative changes and technological advancements.

Legislative Changes

The Uruguay Round Agreements Act (URAA) is a significant example of legislative change that impacted patent terms. Prior to the URAA, patent terms were 17 years from the grant date, which incentivized patentees to delay prosecuting their patents. The URAA changed the patent term to 20 years from the effective filing date, promoting timely disclosure of innovations[2].

Technological Advancements

Technological advancements have led to the development of new tools and databases for patent searching and analysis. The USPTO's Patent Public Search tool, Global Dossier, and other international databases like the European Patent Office's esp@cenet and the World Intellectual Property Organization's PATENTSCOPE, facilitate comprehensive patent searches[4].

Case Study: U.S. Patent 10,087,493

To illustrate the concepts discussed, let's consider U.S. Patent 10,087,493, though the specific details of this patent are not provided here. Here’s how one might analyze such a patent:

Identifying the Invention

The first step is to identify the invention described in the patent. This involves reading the abstract, summary, and detailed description sections to understand the core concept of the invention.

Analyzing the Claims

  • Independent Claims: Review the independent claims to determine the broadest scope of protection granted by the patent.
  • Dependent Claims: Examine the dependent claims to see how they further limit the scope of the independent claims.

Prior Art and Novelty

Check the prior art cited in the patent and any office actions to understand how the patent office determined the novelty and non-obviousness of the invention.

Patent Scope Metrics

Apply metrics such as independent claim length and count to assess the breadth and clarity of the patent claims. This can help in understanding the likelihood of the patent being granted and the potential for litigation.

Tools for Patent Analysis

Several tools are available for analyzing patents:

Patent Public Search

The USPTO's Patent Public Search tool provides enhanced access to prior art and allows users to search and analyze patent documents efficiently[4].

Global Dossier

This service provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications[4].

Patent and Trademark Resource Centers (PTRCs)

These centers offer local search resources and training in patent search techniques, which can be invaluable for detailed analysis[4].

Challenges in Patent Litigation

Patent litigation can be complex and costly. The need for a small claims patent court has been discussed to address issues related to the high costs and complexity of patent litigation. Studies by the Administrative Conference of the United States (ACUS) have explored the feasibility and structure of such a court[5].

Best Practices for Patent Search and Analysis

  • Conduct Thorough Searches: Use multiple databases and tools to ensure comprehensive coverage of prior art.
  • Analyze Claims Carefully: Understand the independent and dependent claims to determine the scope of protection.
  • Consult Experts: Utilize resources from Patent and Trademark Resource Centers and seek advice from legal practitioners if necessary.

Key Takeaways

  • Patent Claims Define Scope: Claims are the legal boundaries of a patent and must be carefully crafted and analyzed.
  • Legislative Changes Impact Patents: Changes like the URAA have significant effects on patent terms and strategies.
  • Technological Tools Facilitate Analysis: Modern databases and tools make patent searching and analysis more efficient.
  • Challenges in Litigation: High costs and complexity in patent litigation highlight the need for reforms like a small claims patent court.

FAQs

What is the role of the USPTO in granting patents?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that inventions meet the criteria for novelty, non-obviousness, and utility[1].

How do legislative changes affect patent terms?

Legislative changes, such as the URAA, can alter the patent term and incentives for patentees. For example, the URAA changed the patent term from 17 years from the grant date to 20 years from the effective filing date[2].

What metrics can be used to measure patent scope?

Metrics such as independent claim length and independent claim count can be used to measure patent scope and assess the breadth and clarity of patent claims[3].

What tools are available for patent searching and analysis?

Tools like the USPTO's Patent Public Search, Global Dossier, and resources from Patent and Trademark Resource Centers are available for comprehensive patent searching and analysis[4].

Why is there a discussion about a small claims patent court?

The discussion about a small claims patent court is driven by the need to address the high costs and complexity of patent litigation, making it more accessible for smaller entities and individuals[5].

Sources

  1. U.S. Patent and Trademark Office (USPTO) | USAGov
  2. Hyatt v. United States Patent and Trademark Office
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. Search for patents - USPTO
  5. U.S. Patent Small Claims Court

More… ↓

⤷  Subscribe

Details for Patent 10,087,493

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. COTAZYM pancrelipase Capsule, Delayed Release 020580 December 09, 1996 10,087,493 2040-03-30
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 April 30, 2009 10,087,493 2040-03-30
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 June 10, 2011 10,087,493 2040-03-30
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 March 14, 2013 10,087,493 2040-03-30
Digestive Care, Inc. PERTZYE pancrelipase Capsule, Delayed Release 022175 May 17, 2012 10,087,493 2040-03-30
Digestive Care, Inc. PERTZYE pancrelipase Capsule, Delayed Release 022175 October 06, 2016 10,087,493 2040-03-30
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.